
Aurora Cannabis Inc. (NASDAQ:ACB) shares surged after the company reported fiscal second-quarter 2026 results, showing higher revenue and profitability, but a net loss compared to the prior year.
The company missed analyst earnings expectations but beat revenue expectations. Reported GAAP EPS was a loss of $0.19, missing the $0.02 consensus estimate, while sales totaled $65.64 million, topping the $63.79 million forecast.